Kenya - English - Pharmacy and Poisons Board

getz pharma (private) limited 29-30/27, korangi industrial area, karachi 74900 - sacubitril + valsartan - film-coated tablet - 49mg+51mg - valsartan and sacubitril

Kenya - English - Pharmacy and Poisons Board

sacubitril + valsartan - film-coated tablet - 97mg + 103mg - valsartan and sacubitril

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

nvs kenya limited, kenya - sacubitril valsartan sodium hydrate - film coated tablet - 100

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

nvs kenya limited, kenya - sacubitril valsartan sodium hydrate - film coated tablet - 200

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cipla medpro (pty) ltd - tablet - 24,3 mg 25,7 mg - each tablet contains sacubitril 24,3 mg valsartan 25,7 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cipla medpro (pty) ltd - tablet - 48,6 mg 51,4 mg - each tablet contains sacubitril 48,6 mg valsartan 51,4 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cipla medpro (pty) ltd - tablet - 97,2 mg 102,8 mg - each tablet contains sacubitril 97,2 mg valsartan 102,8 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - hydrochlorothiazide 12.5mg; quinapril hydrochloride 10.832mg equivalent to 10 mg quinapril free base;   - film coated tablet - 12.5mg/10mg - active: hydrochlorothiazide 12.5mg quinapril hydrochloride 10.832mg equivalent to 10 mg quinapril free base   excipient: candelilla wax crospovidone heavy magnesium carbonate lactose monohydrate magnesium stearate opadry pink oy-s-6937 povidone

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - hydrochlorothiazide 12.5mg; quinapril hydrochloride 21.664mg equivalent to 20 mg quinapril free base.;   - film coated tablet - 12.5mg/20mg - active: hydrochlorothiazide 12.5mg quinapril hydrochloride 21.664mg equivalent to 20 mg quinapril free base.   excipient: candelilla wax crospovidone heavy magnesium carbonate lactose monohydrate magnesium stearate opadry pink oy-s-6937 povidone

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril;  ; quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril - film coated tablet - 10 mg - active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.